Related Experiment Video
Updated: May 1, 2026

11:12
Driving Simulation in the Clinic: Testing Visual Exploratory Behavior in Daily Life Activities in Patients with Visual Field Defects
Published on: September 18, 2012
20.3K
[Mild dementia and driving ability. Part 2: Assessment and its consequences in practice]
1Psykiatrien i Region Syddanmark, Gerontopsykiatrisk Afdeling Haderslev, Skallebækvej 5, 6100, Haderslev, Dänemark, dirk.wolter@rsyd.dk.
Zeitschrift Fur Gerontologie Und Geriatrie
|March 29, 2014
Summary
Assessing driving fitness in dementia requires a comprehensive approach. While moderate to severe dementia prohibits driving, mild cases may allow it temporarily, necessitating careful, individualized evaluation.
Area of Science:
- Traffic and transport psychology
- Medical statistics
Background:
- Safe driving relies on complex sensory and mental processes.
- Diseases and physiological changes can impair driving performance.
- Dementia significantly impacts driving ability over time.
Purpose of the Study:
- To discuss the assessment of driving fitness in patients with dementia.
- To highlight the importance of a comprehensive evaluation beyond cognitive function.
- To guide physicians on counseling patients regarding driving cessation.
Main Methods:
- Review of legal frameworks and essentials in traffic psychology and statistics.
- Discussion of various assessment approaches and tools for driving ability.
- Emphasis on considering overall functioning and risk factors.
Main Results:
- Moderate to severe dementia renders individuals unfit to drive.
- Driving ability may be preserved in mild dementia for a period.
- No single test can definitively determine fitness to drive in mild dementia.
Conclusions:
- Driving ability is inevitably lost during the course of dementia.
- Prompt discussion of driving fitness is crucial upon dementia diagnosis.
- Physicians should counsel and support patients and families through driving cessation.
More Related Videos
Related Concept Videos
Dementia l: Introduction
35
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
35
Dementia
687
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
687
Alzheimer Disease l: Introduction
21
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
21
Alzheimer's Disease: Overview
1.7K
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.7K

